Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Study of Radiotherapy Alone vs With Concurrent Chemotherapy With MTX or VBMF (VCR/BLEO/MTX/5-FU) vs Subsequent Chemotherapy vs Concurrent and Subsequent Chemotherapy in Patients With Advanced Head and Neck Cancer

NCT00002476 is registered in ClinicalTrials.gov with Cancer Research UK as lead sponsor.

NCT NCT00002476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Study of Radiotherapy Alone vs With Concurrent Chemotherapy With MTX or VBMF (VCR/BLEO/MTX/5-FU) vs Subsequent Chemotherapy vs Concurrent and Subsequent Chemotherapy in Patients With Advanced Head and Neck Cancer
Lead sponsor
Cancer Research UK
Phase
Phase 3
Overall status
Completed
Start date
January 31, 1990
Completion date
January 31, 2010
Enrollment
Not reported
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer